| Local recurrence | Patients | ||||
---|---|---|---|---|---|---|
No | Yes | |||||
N=90 | N=8 | N=98 | ||||
KRAS Mutation | ||||||
  No | 67 | (74.4%) | 8 | (100.0%) | 75 | (76.5%) |
  yes | 23 | (25.6%) | 0 | (0.0%) | 23 | (23.5%) |
BRAF Mutation | ||||||
  No | 89 | (98.9%) | 7 | (87.5%) | 96 | (98.0%) |
  yes | 1 | (1.1%) | 1 | (12.5%) | 2 | (2.0%) |
PIK3CA Mutation | ||||||
  No | 86 | (95.6%) | 8 | (100.0%) | 94 | (95.9%) |
  yes | 4 | (4.4%) | 0 | (0.0%) | 4 | (4.1%) |
All mutations | ||||||
At least one mutation | ||||||
  No | 65 | (72.2%) | 7 | (87.5%) | 72 | (73.5%) |
  yes | 25 | (27.8%) | 1 | (12.5%) | 26 | (26.5%) |
Nb of mutations | ||||||
  0 | 65 | (72.2%) | 7 | (87.5%) | 72 | (73.5%) |
  1 | 22 | (24.4%) | 1 | (12.5%) | 23 | (23.5%) |
  2 | 3 | (3.3%) | 0 | (0.0%) | 3 | (3.1%) |